Kentuckiana Pulmonary Associates
Louisville, Kentucky, United States
Medical clinic in Louisville, Kentucky
100 W Market St #2, Louisville, KY 40202
About Kentuckiana Pulmonary Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
16
United Therapeutics
11
Gilead Sciences
4
Aires Pharmaceuticals, Inc.
2
Eiger BioPharmaceuticals
2
Reata Pharmaceuticals, Inc.
2
Bellerophon Pulse Technologies
1
Geno LLC
1
Integrated Diagnostics
1
Lung Biotechnology PBC
1
Pulmonary Hypertension Association, Inc.
1
Clinical Trials at Kentuckiana Pulmonary Associates
During the past decade, Kentuckiana Pulmonary Associates conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 19 clinical trials were completed, i.e. on
average, 126.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 11 clinical trials were completed. i.e. 1100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
2006-10-01
2011-04-01
Completed
349
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
2008-05-01
2012-04-01
Completed
742
Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
2008-10-17
2020-12-07
Completed
550
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
2008-09-01
2010-06-01
Completed
49
Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
2008-07-01
2011-04-01
Terminated
63
(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
2008-12-01
2011-02-01
Terminated
494
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
2009-07-01
2011-02-01
Terminated
40
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kentuckiana Pulmonary Associates" #1 sponsor was "Actelion" with 16 trials, followed by "United Therapeutics" with 11 trials
sponsored, "Gilead Sciences" with 4 trials sponsored, "Aires Pharmaceuticals, Inc." with 2 trials sponsored and "Eiger BioPharmaceuticals"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kentuckiana Pulmonary Associates"
#1 collaborator was "Lung Biotechnology PBC" with 2 trials as a collaborator, "Canadian Heart Research Centre" with 1 trials as a collaborator and "University of Washington, the Collaborative Health Studies Coordinating Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Kentuckiana Pulmonary Associates
According to Clinical.Site data, the most researched conditions in "Kentuckiana Pulmonary Associates" are
"Pulmonary Arterial Hypertension" (27 trials), "Pulmonary Hypertension" (10 trials), "Idiopathic Pulmonary Fibrosis" (4 trials), "Chronic Obstructive Pulmonary Disease" (2 trials) and "Bronchiectasis" (1 trials). Many other conditions were trialed in "Kentuckiana Pulmonary Associates" in a lesser frequency.
Clinical Trials Intervention Types at Kentuckiana Pulmonary Associates
Most popular intervention types in "Kentuckiana Pulmonary Associates" are "Drug" (38 trials), "Other" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Macitentan" (6 trials), "Selexipag" (3 trials), "placebo" (3 trials) and "Ambrisentan" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kentuckiana Pulmonary Associates
The vast majority of trials in "Kentuckiana Pulmonary Associates" are
42 trials for "All" genders.
Clinical Trials Status at Kentuckiana Pulmonary Associates
Currently, there are NaN active trials in "Kentuckiana Pulmonary Associates".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 25 completed trials in Kentuckiana Pulmonary Associates,
undefined suspended trials,
and 16 terminated clinical trials to date.
Out of the total trials that were conducted in Kentuckiana Pulmonary Associates, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 25 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".